(Q54527845)

30 May 2018

title

Impact of MDM2 single nucleotide polymorphism on tumor onset in head and neck squamous cell carcinoma. (English)

1 reference

30 May 2018

single-nucleotide polymorphism

main subject

1 reference

Masashi Nakashima

1

1 reference

30 May 2018

Satoru Kondo

2

1 reference

30 May 2018

Yoshinori Shimizu

3

1 reference

30 May 2018

Naohiro Wakisaka

4

1 reference

30 May 2018

Shigeyuki Murono

5

1 reference

30 May 2018

Mitsuru Furukawa

6

1 reference

30 May 2018

Tomokazu Yoshizaki

7

1 reference

30 May 2018

language of work or name

English

0 references

publication date

1 July 2008

1 reference

30 May 2018

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Acta Oto-Laryngologica

1 reference

30 May 2018

volume

128

1 reference

30 May 2018

page(s)

808-813

1 reference

30 May 2018

issue

7

1 reference

30 May 2018

cites work

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

The MDM2 gene amplification database

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

MDM2 SNP309 accelerates colorectal tumour formation in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

Functions of the MDM2 oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li-Fraumeni syndrome and related phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

A polymorphism in HDM2 (SNP309) associates with early onset in superficial tumors, TP53 mutations, and poor outcome in invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

MDM2 SNP309 and SNP354 are not associated with lung cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

MDM2 309T>G polymorphism and risk of lung cancer in a Korean population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

p53 Codon 72 and MDM2 SNP309 Polymorphisms and Age of Colorectal Cancer Onset in Lynch Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

10.1080/00016480701724904

21 January 2018

Identifiers

DOI

1 reference

30 May 2018

PubMed ID

18568525

1 reference

30 May 2018